Shri Shail Herbs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.85 M
as on 03-07-2024
- Revenue -20.93%
(FY 2020)
- Profit -76.51%
(FY 2020)
- Ebitda -149.71%
(FY 2020)
- Net Worth -214.53%
(FY 2020)
- Total Assets -7.35%
(FY 2020)
About Shri Shail Herbs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.85 M.
Rajendra Kale, Vrunda Kate, Sarika Kale, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2014PTC259136
- Company No.
259136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Shri Shail Herbs Private Limited offer?
Shri Shail Herbs Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Medicinal Plant, Fresh Flowers, Plants & Trees, Outdoor Plant, Herbal Seeds, Ayurvedic,Herbal Products & Medicine, Ayurvedic Immunity Booster, Child and Baby Care Products, Baby Care Products.
Who are the key members and board of directors at Shri Shail Herbs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Kale  | Director | 05-Nov-2014 | Current |
| Vrunda Kate | Director | 05-Nov-2014 | Current |
| Sarika Kale | Director | 05-Nov-2014 | Current |
| Rajshri Deshmukh | Director | 05-Nov-2014 | Current |
Financial Performance of Shri Shail Herbs.
Shri Shail Herbs Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 20.93% decrease. The company also saw a substantial fall in profitability, with a 76.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 214.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Shail Herbs?
In 2020, Shri Shail Herbs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 29 Aug 2017 | ₹0.85 M | Open |
How Many Employees Work at Shri Shail Herbs?
Unlock and access historical data on people associated with Shri Shail Herbs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Shail Herbs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Shail Herbs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
